Clinical trials of her vaccine Covid-19 The American biotechnology company Moderna was launched in thousands of children aged 6 months to 11 years.
The clinical trial involves a total of 6,750 children in the United States and Canada, the statement said. Modern, as broadcast by the French Agency and rebroadcast by the Athenian News Agency.
Moderna has developed a vaccine against Covid-19 for adults based on mRNA technology.
We just announced that the first participants have been dosed in the Phase 2/3 study, called the KidCOVE study, of mRNA-1273, our vaccine candidate against COVID-19, in children ages 6 months to less than 12 years. Read more: https://t.co/FpQ2NCcRxR pic.twitter.com/oWZ0UET8e1
– Modern (@moderna_tx) March 16, 2021

Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.